Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01939028 · ClinicalTrials.gov registry record · NA
Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery
A NA study, sponsored by Case Comprehensive Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT01939028 is a NA study that was terminated before completion, run by Case Comprehensive Cancer Center. The registered enrollment target is 58 participants.
The verdict
NCT01939028, a NA study, was terminated before completion, sponsored by Case Comprehensive Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
This clinical trial studies lymph node mapping in patients with newly diagnosed endometrial cancer undergoing surgery. Lymph node mapping may help in planning surgery to remove endometrial cancer and affected lymph nodes.
Interventions
- PROCEDURE therapeutic conventional surgery
- PROCEDURE sentinel lymph node biopsy
- DRUG indocyanine green solution
- DRUG isosulfan blue
- PROCEDURE lymph node mapping
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2013-07 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01939028
The ClinicalTrials.gov registry entry for NCT01939028 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which therapeutic conventional surgery is the first listed.
NCT01939028 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01939028 about?
NCT01939028 is a clinical study titled "Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery". This clinical trial studies lymph node mapping in patients with newly diagnosed endometrial cancer undergoing surgery. Lymph node mapping may help in planning surgery to remove endometrial cancer and affected lymph nodes.
What is the current status of trial NCT01939028?
This trial is currently terminated. It is a NA study. The enrollment target is 58 participants. The study started on 2013-07. Estimated completion is 2016-10.
What interventions are being tested in trial NCT01939028?
The interventions under investigation include: therapeutic conventional surgery (PROCEDURE), sentinel lymph node biopsy (PROCEDURE), indocyanine green solution (DRUG), isosulfan blue (DRUG), lymph node mapping (PROCEDURE).
Who is sponsoring clinical trial NCT01939028?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.